Electra City Tower
58 Harakevet St.
Tel Aviv
6777016
Sapir Malul
Sapir is a lawyer in our firm’s Capital Market department, who specializes in the provision of ongoing legal counsel to entities operating in the capital market and securities.
Sapir provides ongoing legal counsel to corporations licensed to operate as investment advisers, investment marketers or portfolio managers, as well as to private companies, investment funds, trading platforms and financial entities requiring guidance in relation to aspects of securities law, corporate law and financial regulations, as well as representation before the Israel Securities Authority.
Prior to joining Barnea, Sapir worked at a boutique law firm specializing in securities law and the capital market, and completed her internship at the Israel Securities Authority in its Investments department.
Education:
The Interdisciplinary Center Herzliya (LL.B) 2014
The Interdisciplinary Center Herzliya (BA, Business Administration – Finance) 2014
Admission:
Member of Israel Bar Association since 2015
News and updates - Sapir Malul:
Charges against Our Client in Utrade Case Dropped
Dr. Zvi Gabbay, Adv. Moran Bickel, and Adv. Sapir Malul represented Rafi Bar-Lev in a hearing before the Tel Aviv District Attorney's Office. The DA's Office was considering filing an indictment against Bar-Lev for fraudulent receipt, but instead chose to close the case against him.
Israel Securities Authority Defeated in Proceeding against Portfolio Manager
The Administrative Enforcement Committee rejected an administrative claim filed by the Israel Securities Authority against portfolio manager Ran Amitai for using inside information on a deal with the biotechnology company Compugen. Ran Amitai and Cramim Capital Markets were represented by Dr. Zvi Gabbay and Adv. Sapir Malul.
Hedge Funds Do Not Need Regulation
Dr. Zvi Gabbay, Partner and Adv. Sapir Malul from the Capital Markets & Securities Department at Barnea & Co. express their views in an article for The Marker that the damage involved in applying the regulatory regime for hedge funds is immeasurably greater than the benefits, and may even cause a collapse of the entire industry.